Effects of the aryl linker and the aromatic substituent on the anti-HCV activities of aryl diketoacid (ADK) analogues

Jinyoung Kim, Ki Sun Kim, Hyo Seon Lee, Kwang Su Park, Sun Young Park, Seock Yong Kang, Soo Jae Lee, Hyung Soon Park, Dong Eun Kim, Youhoon Chong

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Based on our pharmacophore model of the aryl diketoacids (ADKs), we designed and prepared a series of novel ADK analogues, which showed potent inhibitory activities against the NS5B polymerase in the submicromolar range. Pharmacophore-guided docking study revealed that the antiviral activities of the ADKs are highly dependent upon the aryl linker as well as the size and position of the aromatic substituent. It is of another importance that, unlike previously reported ADKs, three ADK analogues synthesized in this study effectively blocked Hepatitis C Virus (HCV) replication in the replicon systems.

Original languageEnglish
Pages (from-to)4661-4665
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume18
Issue number16
DOIs
StatePublished - 15 Aug 2008
Externally publishedYes

Keywords

  • Aromatic substituent
  • Aryl diketoacid (ADK)
  • Aryl linker
  • Hepatitis C virus (HCV)
  • Pharmacophore-guided docking

Fingerprint

Dive into the research topics of 'Effects of the aryl linker and the aromatic substituent on the anti-HCV activities of aryl diketoacid (ADK) analogues'. Together they form a unique fingerprint.

Cite this